For decades, creatine monohydrate has been the gold standard supplement for muscle growth and athletic performance. Now, it’s stepping out of the gym and into the neurology lab—with researchers investigating whether it could help fight Alzheimer’s disease.
A new pilot study from the University of Kansas suggests that creatine may improve brain energy metabolism and even enhance certain aspects of cognition in people with Alzheimer’s.
Could this simple, affordable supplement become part of the future of dementia care?
Let’s break down the science.
I. A New Hope for Brain Energy
Alzheimer’s: More Than Plaques
For years, Alzheimer’s disease research has focused on amyloid beta plaques and tau tangles. But there’s another major factor at play: brain energy metabolism.
Alzheimer’s is increasingly understood as a bioenergetic crisis. The brain—an organ that consumes roughly 20% of the body’s energy—literally struggles to generate enough fuel. When neurons can’t produce adequate energy, cognitive decline accelerates.
The CABA Pilot Trial
The CABA Pilot TrialThe “CABA” study (Creatine to Augment Bioenergetics in Alzheimer’s) was designed to test a simple question:
Can creatine monohydrate increase brain energy stores and improve cognition in people with Alzheimer’s?
The answer, based on this early-stage human trial, appears promising.
II. The Science: Why Creatine?
ATP: The Brain’s Energy Currency
Every thought, memory, and neural signal depends on ATP (adenosine triphosphate)—the body’s primary energy molecule.
Creatine plays a crucial role in replenishing ATP. It acts as a rapid energy buffer system:
- Creatine → Phosphorylated creatine (PCr)
- PCr donates phosphate groups to regenerate ATP
- ATP powers neuronal function
The “Energy Shuttle” System
Phosphorylated creatine acts like an energy shuttle, transporting high-energy phosphate groups to cells with high metabolic demand—such as neurons.
In Alzheimer’s disease, mitochondrial dysfunction reduces ATP production. By increasing brain creatine availability, researchers aim to restore energy balance and protect neurons.
Preclinical Wins
Animal studies in mouse models of Alzheimer’s showed:
- Reduced amyloid beta accumulation
- Reduced phosphorylated tau
- Improved mitochondrial function
- Evidence of neuroprotection
These preclinical findings paved the way for human trials.
III. The Study Results: Concrete Numbers
High Feasibility & Compliance
Out of 20 enrolled participants:
- 19 maintained ≥80% compliance
- Seniors tolerated supplementation well
- Dosing was simple and practical
This matters. If an intervention isn’t easy to follow, it won’t scale.
Brain Impact: 11% Increase in Brain Creatine
Researchers used ¹H Magnetic Resonance Spectroscopy (¹H MRS) to measure brain creatine levels.
After 8 weeks:
- Brain total creatine increased from 330.5 IU to 366.9 IU
- That’s an 11% increase
- Statistical significance: p < .001
This is a substantial biological signal, especially in a neurodegenerative population.
Cognitive Breakthroughs
Beyond brain chemistry, cognitive performance improved:
- Fluid Cognition: Significant improvement (p = .004)
- Working Memory (List Sorting Test): Significant improvement (p = .001)
- Oral Reading Recognition & Pronunciation: Marked improvement
- Total Cognition Score: Significant improvement (p = .02)
For a short, 8-week intervention in diagnosed Alzheimer’s patients, these changes are notable.
Safety Profile
Side effects were minimal:
- Mild cramping
- Occasional nausea
- Symptoms resolved quickly
Creatine monohydrate remains one of the most extensively studied and safest dietary supplements available.
IV. Key Statistics at a Glance
| Metric | Baseline | 8-Week Result | Statistical Significance (p-value) |
|---|---|---|---|
| Brain Creatine (IU) | 330.5 | 366.9 | < 0.001 |
| Total Cognition Score | 75.3 | 78.6 | 0.02 |
| Fluid Cognition | 59.1 | 63.5 | 0.004 |
| List Sorting Memory | 66.2 | 74.2 | 0.001 |
V. Practical Takeaways: Dosage and Protocol
If you’re wondering how creatine was used in this Alzheimer’s study, here’s the exact protocol.
The Dose
- 20 grams per day
- Creatine monohydrate form
The Method
- Split into two 10g doses
- Stirred into beverages
- Taken daily
The Duration
- 8 weeks
- Measurable changes in both brain creatine levels and cognition observed within this timeframe
Important: This dosage is higher than typical “fitness” dosing (3–5g/day). Anyone considering creatine for cognitive purposes should consult a healthcare professional—especially individuals with kidney disease or other medical conditions.
VI. Conclusion: A New Frontier in Dementia Treatment Research
This was a small, single-arm pilot trial—not a definitive cure.
However:
- An 11% boost in brain creatine
- Statistically significant cognitive improvements
- Strong compliance
- Minimal side effects
That’s a powerful signal.
The next step? Larger, double-blind, placebo-controlled trials to confirm these findings and determine long-term benefits.
If future studies replicate these results, creatine monohydrate—an inexpensive, widely available supplement—could become a valuable addition to Alzheimer’s treatment strategies.
Rethinking Creatine Beyond Muscle
For years, creatine has been known as “muscle fuel.”
Now, it may also be brain fuel.
In the growing field of neuroenergetics, restoring cellular energy might be one of the most promising strategies for slowing cognitive decline. And if something as simple as creatine can safely support brain energy metabolism, that’s a major development in dementia treatment research for 2026 and beyond.
Journal Reference: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70101
0 comments